Form D
View Original Filing
Notice of Exempt Offering of Securities
Item 1. Issuer's Identity
Name of Issuer:
BIONANO GENOMICS, INC
Jurisdiction of Incorporation/Organization
DE
Year of Incorporation/Organization
Over Five Years Ago
Item 2 Issuer Principal Place of Business and Contact Information
9640 TOWNE CENTRE DRIVE
SUITE 100
SAN DIEGO, CA 92121
Phone Number:
subscription required
Item 3. Related Persons
Name
R. ERIK HOLMLIN
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
DAVID L. BARKER
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
BRIAN HALAK
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
ALBERT A. LUDERER
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
TRACY WARREN
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
HAN CAO
Address
subscription required
Relationship(s)
Clarification of Response
Item 4. Industry Group
PHARMACEUTICALS
Item 5. Issuer Size
Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE
Item 6. Federal Exemptions and Exclusions Claimed
Item 7. Type of Filing
New Notice
Date of First Sale in this Offering:
09/17/2013
Item 8. Duration of Offering
Does the issuer intend this offering to last more than one year?
No
Item 9. Type(s) of Securities Offered
- Debt
- Option, Warrant or Other Right to Acquire Another Security
- Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security
Item 10. Business Combination Transaction
Is this offering being made in connection with a business combination
transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response
Item 11. Minimum Investment
Minimum Investment accepted from any outside investor
0
Item 13. Offering and Sales Amounts
Total Offering Amount
13663054
Total Amount Sold
10001000
Total Remaining to be Sold
3662054
Clarification of Response
TOTAL OFFERING AMOUNT LISTED ABOVE INCLUDES AN AGGREGATE OF $3,110,509 RECEIVABLE UPON THE EXERCISE OF WARRANTS TO PURCHASE SHARES OF THE COMPANY'S SERIES B-1 PREFERRED STOCK. SUCH WARRANTS HAVE NOT YET BEEN EXERCISED.
Item 14. Investors
Securities in the offering have been or may be sold to persons
who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
5
Item 15. Sales Commissions and Finders' Fees Expenses
Sales Commissions:
0.0
Finders' Fees
0.0
Clarification of Response
Item 16. Use of Proceeds
Provide the amount of the gross proceeds of the offering
that has been or is proposed to be used for payments to any of the persons required
to be named as executive officers,directors or promoters in response to Item 3 above.
0.0
Clarification of Response
Signature and Submission
Issuer Name
BIONANO GENOMICS, INC
Issuer Signature
ERIK HOLMLIN, PH.D.
Signer Name
ERIK HOLMLIN, PH.D.
Signer Title
PRESIDENT AND CEO
Signature Date
09/26/2013